Literature DB >> 28658777

Detection of Compound Heterozygous Sickle Cell-β+ Thalassaemia in a Patient with Extreme Weakness, Mild Jaundice and Moderate Anaemia - A Case Report.

Subhash Chandra1, Mostafa Ali2, Pooja Mishra3, Ashok Kumar Kapoor4, Yamini Jindal5.   

Abstract

A 16-year-old female complained of extreme weakness. She had moderate anaemia; her Haemoglobin (Hb) was 7.7 gm/dl. Peripheral blood smear showed few sickled red cells. Sickle cell test was positive. High-Performance Liquid Chromatography (HPLC) revealed elevated levels of HbS (38.4%) and HbF (15.7%). In addition, HbA2 concentration was 3.8% and HbA concentration was 42.1%. Results suggested a diagnosis of compound heterozygous sickle cell-β+ thalassaemia. Sickle cell test was also positive with blood of patient's brother; Hb HPLC examination showed relatively low concentration of HbS (25.2%) suggesting a diagnosis of sickle cell trait. Chromatogram of patient's step sister suggested a diagnosis of thalassaemia trait. Findings of this study suggested that abnormal genes were inherited in the patient from both the parents. It was interpreted that repeated haemolysis in the patient might have contributed to anaemia, weakness, rise in indirect bilirubin and jaundice. Furthermore, high level of HbF (>12%) may interfere with polymerization of sickle haemoglobin suggesting beneficial effects of HbF-inducing agents which may inhibit sickling.

Entities:  

Keywords:  Bilirubin; Defective globin chain synthesis; Gene; High-performance liquid chromatography

Year:  2017        PMID: 28658777      PMCID: PMC5483679          DOI: 10.7860/JCDR/2017/24471.9778

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

1.  Sickle-cell trait in southern India.

Authors:  H LEHMANN; M CUTBUSH
Journal:  Br Med J       Date:  1952-02-23

2.  The clinical features of sickle-cell- thalassaemia in Jamaica.

Authors:  G R Serjeant; M T Ashcroft; B E Serjeant; P F Milner
Journal:  Br J Haematol       Date:  1973-01       Impact factor: 6.998

3.  Hb S-β-thalassemia: molecular, hematological and clinical comparisons.

Authors:  Graham R Serjeant; Beryl E Serjeant; Raphael A Fraser; Ian R Hambleton; Douglas R Higgs; Andreas E Kulozik; Alan Donaldson
Journal:  Hemoglobin       Date:  2011       Impact factor: 0.849

4.  The screening and morbidity pattern of sickle cell anemia in chhattisgarh.

Authors:  Sumanta Panigrahi; P K Patra; P K Khodiar
Journal:  Indian J Hematol Blood Transfus       Date:  2014-06-13       Impact factor: 0.900

5.  Clinical, hematologic and molecular variability of sickle cell-β thalassemia in western India.

Authors:  Malay B Mukherjee; Anita H Nadkarni; Ajit C Gorakshakar; Kanjaksha Ghosh; Dipika Mohanty; Roshan B Colah
Journal:  Indian J Hum Genet       Date:  2010-09

Review 6.  Sickle cell disease in Middle East Arab countries.

Authors:  Mohsen A F El-Hazmi; Ali M Al-Hazmi; Arjumand S Warsy
Journal:  Indian J Med Res       Date:  2011-11       Impact factor: 2.375

7.  The compound state: Hb S/beta-thalassemia.

Authors:  Maria Stella Figueiredo
Journal:  Rev Bras Hematol Hemoter       Date:  2015-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.